Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG and Cyclosporine for MDS Cytopenia
NCT00005937Phase 2Completed
- Start
- Jun 2000
- Primary completion
- Mar 2008
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin, cyclosporine in myelodysplastic syndrome (MDS). Started Jun 2000; status: completed.
02
Drugs
antithymocyte globulincyclosporine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00005937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005937.